Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients

References

• Nieuwenhuis EE, Escher JC. Early onset IBD: what's the difference? Dig Liver Dis 2008;40:12–15.
   PubMedGoogle Scholar
• Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 2004;18:509–23.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM, Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423–39.
   PubMed Web of Science ®Google Scholar
• Oliva-Hemker M, Escher JC, Moore D, Dubinksy M, Hildebrand H, Koda YK, Refractory inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 2008;47:266–72.
   PubMedGoogle Scholar
• Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005;146:35–40.
   PubMed Web of Science ®Google Scholar
• Van Limbergen LJ, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114–22.
   PubMed Web of Science ®Google Scholar
• Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525–31.
   PubMed Web of Science ®Google Scholar
• Kugathasan S, Fiocchi C. Progress in basic inflammatory bowel disease research. Semin Pediatr Surg 2007;16:146–53.
   PubMedGoogle Scholar
• Kugathasan S, Cohen S. Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studies. Gastroenterology 2008;135:1038–41.
   PubMedGoogle Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427–34.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–94.
   PubMed Web of Science ®Google Scholar
• Tommasini A, Pirrone A, Palla G, Taddio A, Martelossi S, Crovella S, Ventura A. The universe of immune deficiencies in Crohn's disease: a new viewpoint for an old disease? Scand J Gastroenterol 2010;45:1141–9.
   PubMed Web of Science ®Google Scholar
• Boden EK, Snapper SB. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 2008;24:733–41.
   PubMed Web of Science ®Google Scholar
• Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009;31:401–11.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057–61.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330–6.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, Neurath MF. Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006;55:671–80.
   PubMed Web of Science ®Google Scholar
• Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003;170:3939–43.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39:537–45.
   PubMed Web of Science ®Google Scholar
• Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004;173:3119–30.
   PubMed Web of Science ®Google Scholar
• Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease. Gastroenterology 2005;128:1868–78.
   PubMed Web of Science ®Google Scholar
• Holmen N, Lundgren A, Lundin S, Bergin AM, Rudin A, Sjovall H, Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006;12:447–56.
   PubMed Web of Science ®Google Scholar
• Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, Papadakis KA. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol 2007;125:281–90.
   PubMed Web of Science ®Google Scholar
• Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA, Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007;13:191–9.
   PubMed Web of Science ®Google Scholar
• Inflammatory bowel disease in children and adolescents: recommendations for diagnosis – the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1–7.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6.
   PubMedGoogle Scholar
• Perminow G, Reikvam DH, Lyckander LG, Brandtzaeg P, Vatn MH, Carlsen HS, Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease. Inflamm Bowel Dis 2009;15:1368–78.
   PubMedGoogle Scholar
• Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H, Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997;112:1493–505.
   PubMed Web of Science ®Google Scholar
• Carlsen HS, Yamanaka T, Scott H, Rugtveit J, Brandtzaeg P. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria. Inflamm Bowel Dis 2006;12:1013–24.
   PubMed Web of Science ®Google Scholar
• Choy MY, Walker-Smith JA, Williams CB, Macdonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 1990;31:1365–70.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Patel S, Wu K, Jewell DP. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol 1988;74:382–6.
   PubMedGoogle Scholar
• Halstensen TS, Scott H, Fausa O, Brandtzaeg P. Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia. Scand J Immunol 1993;38:581–90.
   PubMed Web of Science ®Google Scholar
• Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005;206:149–59.
   PubMed Web of Science ®Google Scholar
• Sanarico N, Ciaramella A, Sacchi A, Bernasconi D, Bossu P, Mariani F, Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response. J Leukoc Biol 2006;80:555–62.
   PubMedGoogle Scholar
• Mnasria K, Lagaraine C, Velge-Roussel F, Oueslati R, Lebranchu Y, Baron C. Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells. J Leukoc Biol 2008;84:460–7.
   PubMedGoogle Scholar
• Newberry RD. Intestinal lymphoid tissues: is variety an asset or a liability? Curr Opin Gastroenterol 2008;24:121–8.
   PubMedGoogle Scholar
• Nascimbeni R, Di FF, Di BE, Mariani P, Fisogni S, Villanacci V. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 2005;18:681–5.
   PubMed Web of Science ®Google Scholar
• Surawicz CM, Haggitt RC, Husseman M, McFarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 1994;107:755–63.
   PubMed Web of Science ®Google Scholar
• Fell JM, Walker-Smith JA, Spencer J, Macdonald TT. The distribution of dividing T cells throughout the intestinal wall in inflammatory bowel disease (IBD). Clin Exp Immunol 1996;104:280–5.
   PubMedGoogle Scholar
• Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007;7:231–7.
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009;30:616–25.
   PubMed Web of Science ®Google Scholar
• Friedline RH, Brown DS, Nguyen H, Kornfeld H, Lee J, Zhang Y, CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009;206:421–34.
   PubMed Web of Science ®Google Scholar
• Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009;30:646–55.
   PubMed Web of Science ®Google Scholar
• Ricciardelli I, Lindley KJ, Londei M, Quaratino S. Anti tumour necrosis-alpha therapy increases the number of FOXP3+ regulatory T cells in children affected by Crohn's disease. Immunology 2008;125:178–83.
   PubMed Web of Science ®Google Scholar
• Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008;134:491–9.
   PubMed Web of Science ®Google Scholar
• Grindebacke H, Stenstad H, Quiding-Jarbrink M, Waldenstrom J, Adlerberth I, Wold AE, Rudin A. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol 2009;183:4360–70.
   PubMed Web of Science ®Google Scholar